View Activities

Elder Abuse Issues & Capacity Determination in Dementia

Activity Details
  • Credit Amounts:
    • CME: 1.50
    • CNE: 1.50
    • Other: 1.50
    • ASWB ACE: 1.50
  • Cost: Free
  • Release: Jun 1, 2021
  • Expires: May 31, 2024
  • Estimated Time to Complete:
    1 Hour(s)  30 Minutes
  • Average User Rating:
    (4 Ratings)

This was recorded from a live webinar dated June 1, 2021. If you claimed credit for the live session you should not claim credit for this module.


Amy E.  Dougherty Amy E. Dougherty, JD
Bluegrass Elderlaw, PLLC
Life Plan of Kentucky, Inc
Board of Directors Member
Statewide Independent Living Council Chair
Lexington, Kentucky

Gregory A.  Jicha Gregory A. Jicha, MD, PhD
Professor, Neurology
Alzheimer's Disease Research Center
Sanders-Brown Center on Aging
University of Kentucky College of Medicine
Lexington, Kentucky

Needs Statement

Approximately 10% of the population over the age of 65 years (~4.3 million persons) in the United States have been the victims of elder abuse, and this number is expected to double to almost 90 million persons by 2050 unless current trends are altered. Two out of every 3 victims of elder abuse suffer from dementia, many of whom reside in CNFs. Types of abuse include financial, neglect, physical, sexual and verbal and each needs to be recognized and appropriate interventions pursued.

Target Audience

This is for ALL Certified Nursing Facilities personnel in Kentucky.


Upon completion of this educational activity, participants will be able to:
1. Develop an easy to use algorithm for use in capacity determination for those with dementia
2. Describe common types of elder abuse that can occur in residential care facilities
3. Discuss federal guidance for reporting elder abuse, as described in the Federal Elder Justice Act
4. Develop strategies to increase identification of abuse and corrective action plans to eliminate this problem


In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This enduring material is designated for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

IPE Competencies

  • Values/Ethics for Interprofessional Practice
  • Roles/ Responsibilities

The University of Kentucky, College of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).

This educational activity is offered for a maximum of 1.50 ANCC contact hours.

The Kentucky Board of Nursing (KBN) approves The University of Kentucky, College of Nursing (UKCON) as a provider as well. ANCC and KBN approval of a continuing nursing education provider does not constitute endorsement of program content nor commercial sponsors. The University of Kentucky does not approve commercial products. This educational activity is offered for a maximum of 1.8 KBN contact hours.

Provider #: 3-0008-12-21-0197. In order to receive credit, participants complete this CNE activity and submit a credit application and evaluation form online. Certificates may be printed once the evaluation is completed.

UK Healthcare CECentral certifies this activity for 1.50 hours of participation.

As a Jointly Accredited Organization, UK HealthCare CECentral is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. UK HealthCare CECentral maintains responsibility for this course. Social workers completing this course receive 1.50 clinical continuing education credits.

Faculty Disclosure

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months.  An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company. 

Dr. Jicha has received study activity payment for contract research from AbbView, BioHaven, Eisai, and Novartis. All of the relevant financial relationships listed for this individual have been mitigated. No other speakers, planners, or content reviewers have any relevant financial relationships to disclose. 

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.


This activity is provided by UK HealthCare CECentral and the UK College of Nursing in collaboration with UK Sanders Brown Center on Aging.

 The KEEN-CDC Initiative is funded through CMS Grant #2018-04-KY- 0329 and the Kentucky Office of the Inspector General.